Management TeamMoshe Tzabari, CEO, President & Founder.
Moshe Tzabari brings more than 20 years’ experience in taking medical devices and pharmaceuticals from idea to market. Mr. Tzabari served as VP Development and Operations of Intec Pharma (TASE: INTP), CEO of fBit Ltd., and COO of the Dexxon Group’s Perio Products. He received an MBA from the University of Manchester, UK; a BSc in chemical engineering, and a BA in biology, both from the Technion-Israel Institute of Technology.Brian Cooper, CFO & Director.
Mr. Cooper one of the founders and former director and CFO of Retalix Ltd. (Nasdaq: RTLX), a global provider of integrated software solutions for high volume, high complexity consumer goods retailers and distributors that was acquired by NCR Corporation in 2012.
Mr. Cooper is an active early-stage investor in a number of IT and Life Sciences companies, and is currently a member of the board of directors of YCD Multimedia Ltd, GenomeDx Biosciences Inc, Regenecure Ltd, Exonoid Medical Devices Ltd and Everest Corporate Finance Ltd.
Harry Langbeheim, PhD, VP Business Development.
Harry Langbeheim has more than 30 years’ experience in the diagnostics and life science industry. He served as CEO of Matis Medical Ltd. and of Life Science Research Israel Ltd. He was VP and COO at Savyon Diagnostics Ltd. and Director of R&D at Sigma Immunochemicals. Dr. Langbeheim holds a PhD in immunology from the Weizmann Institute of Science in Israel and a Dipl Nat Sc from the Swiss Federal Institute of Technology (ETH).Michal Limor, MD, MBA, VP Medical Affairs.
Dr. Michal Limor has over 10 years’ experience in clinical research organizations (CROs). She served as Project and Operations Manager at Medpace Israel Ltd., was responsible for clinical research at Mindguard Ltd. and monitored clinical trials and trained CRAs at Harrison Clinical Research Israel (HCRI).Erez Adiv, CQE, Quality Assurance Manager.
Erez Adiv was a Co-Founder and Co-CEO of MedicSense, an Israeli clinical and regulatory affairs consultancy firm in the medical device arena. Mr. Adiv has over 20 years’ experience in developing company-tailored regulatory strategies.Gideon Drimer, Director.
Gideon Drimer is President of the Persys Group and an entrepreneur with over 25 years of executive-level experience in industry, both in Israel and the US. Erez Ofer, Director.
Erez Ofer is Deputy to the Managing Director of Johnson & Johnson Medical, Israel. Prior to his current appointment, Mr. Ofer served as Director of Strategic Affairs and as Franchise Director for Orthopedic and Neurosurgery Applications at Johnson & Johnson Medical, Israel.
Scientific and Medical Advisory BoardProfessor Peter Giannoudis MD FRCS Chairperson
Prof. Peter Giannoudis, Chairman of the Academic Department of Trauma & Orthopaedic Surgery, Leeds General Infirmary University Hospital, Leeds UK a 2,500 beds teaching hospital serving a population in the region of 3.5 million. Prof. Giannoudis has over 400 publications of manuscripts in peer-reviewed journals, published 7 personal textbooks on Trauma and Orthopaedic Surgery and 24 Chapters in renowned textbooks of Orthopeadics and Trauma. Prof. Giannoudis is Executive Member and Instructor of British Orthopaedic Association, Instructor of American Academy Orthopaedic Surgeons and conducted AO Masters and Polytrauma courses. Professor Michael Friedman, PhD, Inventor.
Prof. Michael Friedman is the inventor of REGENECURE’s regenerative membrane implant technology. He has extensive experience in the fields of oral drug delivery and industrial pharmaceutics. Prof. Friedman holds 24 US patents. He invented the PerioChip, the flagship product of the Dexxon Group’s Perio Products, and founded Intec Pharma, which develops and markets the Accordion Pill. Prof. Friedman is a faculty member of the School of Pharmacy at the Hebrew University of Jerusalem’s Faculty of Medicine.Professor Rami Mosheiff, MD.
Prof. Rami Mosheiff is Head of the Orthopedic Trauma Center at Hadassah Medical Center in Jerusalem. He is the co-inventor of REGENECURE’s regenerative membrane implant technology. Prof. Mosheiff is Chairman of AOTrauma Europe and a member of the governing body of AOTrauma (AO Foundation, Davos, Switzerland), a 5,000-strong international network of trauma surgeons dedicated to building a community of knowledge and advancing surgical orthopedic practices.
REGENECURE is dedicated to developing and marketing innovative solutions for bone reconstruction. The company brings together a team of experienced developers and entrepreneurs in the field of polymer technology for medical devices with leading scientists and physicians at a major Israeli medical center and school of medicine.
The company leverages 10 years of scientific research on implants for healing delayed and non-union fractures and for accelerating the healing process in fracture management.
REGENECURE Ltd. was established in 2010. After raising capital from private investors, the company opened its state-of-the-art development and manufacturing facilities in Jerusalem.
In 2012, REGENECURE has received ISO 13485:2003 certification for its quality management system for the design, development, manufacture and distribution of polymeric membrane implants for Guided Bone Regeneration.